Skip to main content
Log in

Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

We hypothesized that preoperative and/or postoperative enteral immune-enhanced formulas that are supplemented with arginine, omega-3 fatty acids, and RNA may reduce postoperative complications in patients undergoing esophagectomy for thoracic esophageal squamous cell carcinoma (ESCC).

Methods

Forty patients who underwent esophagectomy were divided into three groups: group A (n = 20) received a control enteral diet (Erental) through the jejunostomy after surgery. group B (n = 6) received an enteral diet supplemented with immune-enhancing substrates (Impact) containing arginine, omega-3 fatty acids, and RNA after surgery. group C (n = 14) received the impact before and after surgery.

Results

Lymphocyte counts in group C on postoperative day (POD) 7 were somewhat higher than that in group A (p = 0.07) and significantly higher than in group B (p = 0.03). Furthermore the incidence of incisional wound infection in group C was significantly lower than that in group A (p = 0.03). Moreover, the duration of postoperative systemic inflammatory response syndrome (SIRS) was significantly shorter in group C than in group A (p < 0.05).

Conclusions

This study reveals that the perioperative immune-enhanced formula may be superior to postoperative control enteral formulas in terms of reducing surgical wound infection and postoperative SIRS, which may result in serious postoperative complications for patients who have undergone esophagectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ando N, Ozawa S, Kitagawa Y, et al. (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232

    Article  PubMed  CAS  Google Scholar 

  2. Ando N, Iizuka T, Ide H, et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology group study-JCOG 9204. J Clin Oncol 21: 4592–4596

    Article  PubMed  Google Scholar 

  3. Gabor S, Renner H, Matzi V, et al. (2005) Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr 93:509–513

    Article  PubMed  CAS  Google Scholar 

  4. Aiko S, Yoshizumi Y, Sugiura Y, et al. (2001) Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today 31: 971–978

    Article  PubMed  CAS  Google Scholar 

  5. Martin LW, Swisher SG, Hofstetter W, et al. (2005) Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242: 392–399

    PubMed  Google Scholar 

  6. Ryan AM, Rowley SP, Healy LA, et al. (2006) Postoesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a special unit. Clin Nutr 25:386–393

    Article  PubMed  Google Scholar 

  7. McCowen KC, Bistrian BR (2003) Immunonutrition: problematic or problem solving? Am J Clin Nutr 77: 764–770

    PubMed  CAS  Google Scholar 

  8. Farreras N, Artigas V, Cardona D, et al. (2005) Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr 24:55–65

    Article  PubMed  Google Scholar 

  9. Xu J, Zhong Y, Jing D, et al. (2006) Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer. World J Surg 30:1284–1289

    Article  PubMed  Google Scholar 

  10. Alvarez W, Mobarhan S (2003) Finding a place for immunonutrition. Nutr Rev 61:214–218

    Article  PubMed  Google Scholar 

  11. Yeh CL, Yeh SL, Lin MT, et al. (2002) Effects of arginine-enriched total parenteral nutrition on inflammatory-related mediator and T-cell population in septic rats. Nutrition 18:631–635

    Article  PubMed  CAS  Google Scholar 

  12. Whitaker MO, Wyche A, Fitzpatrick F, et al. (1979) Triene prostaglandins: prostaglandin D3 and icosapentanoic acids as potential antithrombotic substances. Proc Natl Acad Sci USA 76:5919–5923

    Article  PubMed  CAS  Google Scholar 

  13. Fischer S, Weber PC (1984) Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 307:165–168

    Article  PubMed  CAS  Google Scholar 

  14. Mayer K, Gokorsch S, Fegbeutel C, et al. (2003) Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 167:1321–1328

    Article  PubMed  Google Scholar 

  15. Kulkarni AD, Fanslow WC, Rudolph FB, et al. (1986) Effect of dietary nucleotides on response to bacterial infections. JPEN J Parenter Enteral Nutr 10:169–171

    PubMed  CAS  Google Scholar 

  16. Riso S, Aluffi P, Brugnani M, et al. (2000) Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr 19:407–412

    Article  PubMed  CAS  Google Scholar 

  17. Japanese Society for Esophageal Diseases (1999) Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th Edition, Tokyo, Kanehara Publishing Co

    Google Scholar 

  18. Bone RC, Balk RA, Cerra FB, et al. (1992) ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655

    PubMed  CAS  Google Scholar 

  19. Ateş E, Yilmaz S, Erkasap E, et al. (2004) Perioperative immunonutrition ameliorates the postoperative immune depression in patients with gastrointestinal system cancer (prospective clinical study in 42 patients). Acta Gastroenterol Belg 67:250–254

    PubMed  Google Scholar 

  20. Daly JM, Weintraub FN, Shou J, et al. (1995) Enteral nutrition during multimodal therapy in upper gastrointestinal cancer patients. Ann Surg 221:327–338

    Article  PubMed  CAS  Google Scholar 

  21. Aiko S, Yoshizumi Y, Tsuwano S, et al. (2005) The effect of immediate enteral feeding with a formula containing high levels of ω-3 fatty acids in patients after surgery for esophageal cancer. JPEN J Parenter Enteral Nutr 29:141–147

    Article  PubMed  CAS  Google Scholar 

  22. Wu GH, Zhang YW, Wu ZH (2001) Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastroinetestinal cancer patients. World J Gastroenterol 7:357–362

    PubMed  CAS  Google Scholar 

  23. Tsujinaka T, Kido Y, Ogawa M, et al. (1990) Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer. Am J Gastroenterol 85:1473–1479

    PubMed  CAS  Google Scholar 

  24. Sakurai Y, Oh-Oka Y, Kato S, et al. (2006) Effects of long-term continuous use of immune-enhancing enteral formula on nutritional and immunologic status in non-surgical patients. Nutrition 22:713–721

    Article  PubMed  CAS  Google Scholar 

  25. Endres S, Ghorbani R, Kelly VE, et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265–271

    Article  PubMed  CAS  Google Scholar 

  26. Meydani SN, Endres S, Woods MM, et al. (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocytes proliferation: comparison between young and older woman. J Nutr 121:547–555

    PubMed  CAS  Google Scholar 

  27. Trebble TM, Wootton SA, Miles EA, et al. (2003) Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant. Am J Clin Nutr 78:376–382

    PubMed  CAS  Google Scholar 

  28. Zhao Y, Joshi-Barve S, Barve S, et al. (2004) Eicosapentanoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23:71–78

    PubMed  CAS  Google Scholar 

  29. Denys A, Hichami A, Khan NA (2005) n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and epsilon and the NF-kappaB signaling pathway. J Lipid Res 46:752–758

    Article  PubMed  CAS  Google Scholar 

  30. Braga M, Gianotti L, Radaelli G, et al. (1999) Perioperative immunonutirion in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134:428–433

    Article  PubMed  CAS  Google Scholar 

  31. Weinmann A, Bastian L, Bischoff WE, et al. (1998) Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 14:165–172

    Article  Google Scholar 

  32. von Schacky C (2007) Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10:129–135

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroya Takeuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takeuchi, H., Ikeuchi, S., Kawaguchi, Y. et al. Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer. World J Surg 31, 2160–2167 (2007). https://doi.org/10.1007/s00268-007-9219-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-007-9219-8

Keywords

Navigation